![N-[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-2-phenoxyacetamide chemical structure N-[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-2-phenoxyacetamide (CAS: 110522-74-2) - Chemical Structure and Molecular Formula](/static/img/prod_pic/FT-0771027.png) 
                                        ![N-[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-2-phenoxyacetamide chemical structure thumbnail N-[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-2-phenoxyacetamide (CAS: 110522-74-2) - Chemical Structure Thumbnail](/static/img/prod_pic/FT-0771027.png) 
                                        N-[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-2-phenoxyacetamide
Catalog No: FT-0771027
CAS No: 110522-74-2
- Chemical Name: N-[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-2-phenoxyacetamide
- Molecular Formula: C18H19N5O5
- Molecular Weight: 385.4
- InChI Key: HWSKJANFAKYDDL-GZBFAFLISA-N
- InChI: InChI=1S/C18H19N5O5/c24-7-13-12(25)6-15(28-13)23-10-21-16-17(19-9-20-18(16)23)22-14(26)8-27-11-4-2-1-3-5-11/h1-5,9-10,12-13,15,24-25H,6-8H2,(H,19,20,22,26)/t12-,13+,15+/m0/s1
| Assay | Pack Size | Price | Stock | Action | 
|---|---|---|---|---|
| 98% | 1g | N/A | N/A | |
| 98% | 5g | N/A | N/A | |
| 98% | Bulk Quantity | N/A | N/A | 
| Bolling_Point: | N/A | 
|---|---|
| CAS: | 110522-74-2 | 
| MF: | C18H19N5O5 | 
| Density: | N/A | 
| Melting_Point: | N/A | 
| Product_Name: | N-[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-2-phenoxyacetamide | 
| Flash_Point: | N/A | 
| FW: | 385.37400 | 
| Exact_Mass: | 385.13900 | 
|---|---|
| MF: | C18H19N5O5 | 
| LogP: | 0.55750 | 
| PSA: | 131.62000 | 
| FW: | 385.37400 | 
 
                             
                                                     
                                                     
                                                     
                                                     
                                                     
                                                     
                                                     
                                                     
                                                    